Correction: Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis

No authors listed

Published Erratum

No authors listed. Heart. 2023.

. 2023 Dec 20;110(2):e1.

doi: 10.1136/heartjnl-2022-321328corr1.

No abstract available

Erratum for

Recurrent pericarditis: moving from the middle ages to renaissance.
Lazaros G, Tsioufis C. Lazaros G, et al. Heart. 2023 Jan 27;109(4):250-252. doi: 10.1136/heartjnl-2022-321749. Heart. 2023. PMID: 36316101 No abstract available.
Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis.
Brucato A, Wheeler A, Luis SA, Abbate A, Cremer PC, Zou L, Insalaco A, Lewinter M, Lewis BS, Lin D, Nicholls S, Pancrazi M, Klein AL, Imazio M, Paolini JF. Brucato A, et al. Heart. 2023 Jan 27;109(4):297-304. doi: 10.1136/heartjnl-2022-321328. Heart. 2023. PMID: 36316102 Free PMC article. Clinical Trial.